Promotion of cooperation between enterprises and the public. Research institutions in R & D & I (Q3304849): Difference between revisions
Jump to navigation
Jump to search
(BatchIngestion) |
(Set a claim value: summary (P836): Desenvolvimento de uma previsão para o benefício da aférese em doentes com esclerose múltipla (EM) em impulso agudo. Para esta finalidade, os jogos diagnósticos são desenvolvidos que distinguem respondedores dos não-respondedores para a terapia da plamaférese.) |
||||||
| (One intermediate revision by the same user not shown) | |||||||
| Property / summary: Development of a prediction for the benefit of apheresis in multiple sclerosis (MS) patients in acute thrust. For this purpose, diagnostic kits are developed that distinguish responders from non-responders for plamapheresis therapy. (English) / qualifier | |||||||
readability score: 0.0061547098693049
| |||||||
| Property / summary | Property / summary | ||||||
Desenvolvimento de uma previsão para o benefício da aférese em doentes com esclerose múltipla (EM) em impulso agudo. Para esta finalidade, os jogos diagnósticos são desenvolvidos que distinguem respondedores dos não-respondedores para a terapia da plamaférese. (Portuguese) | |||||||
Latest revision as of 23:36, 9 October 2024
Project Q3304849 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Promotion of cooperation between enterprises and the public. Research institutions in R & D & I |
Project Q3304849 in Germany |
Statements
656,244.0 Euro
0 references
820,305.0 Euro
0 references
80.0 percent
0 references
28 September 2017
0 references
30 June 2023
0 references
Miltenyi Biotec GmbH Niederlassung Teterow
0 references
53°46'17.22"N, 12°34'24.67"E
0 references
17166 - Teterow
0 references
Entwicklung einer Vorhersagemöglichkeit für den Nutzen der Apherese bei Multiple Sklerose (MS) Patienten im akuten Schub. Dazu werden diagnostische Kits entwickelt, die Responder von Non-Respondern für die Plamapherese-Therapie unterscheiden. (German)
0 references
Development of a prediction for the benefit of apheresis in multiple sclerosis (MS) patients in acute thrust. For this purpose, diagnostic kits are developed that distinguish responders from non-responders for plamapheresis therapy. (English)
24 October 2021
0.0061547098693049
0 references
Développement d’une prédiction des bénéfices de l’aphérèse chez les patients atteints de sclérose en plaques (MS) dans la poussée aiguë. Pour ce faire, des kits de diagnostic sont mis au point, qui distinguent les répondeurs des non-répondeurs pour le traitement de la Plamapherese. (French)
6 December 2021
0 references
Ontwikkeling van een voorspelling ten behoeve van aferese bij patiënten met multiple sclerose (MS) in acute stuwkracht. Voor dit doel worden diagnostische kits ontwikkeld die responders onderscheiden van non-responders voor plamaferesetherapie. (Dutch)
19 December 2021
0 references
Sviluppo di una previsione a beneficio dell'aferesi nei pazienti con sclerosi multipla (MS) in spinta acuta. A tal fine, vengono sviluppati kit diagnostici che distinguono i rispondenti dai non rispondenti per la terapia con plamaferesi. (Italian)
18 January 2022
0 references
Desarrollo de una predicción para el beneficio de la aféresis en pacientes con esclerosis múltiple (EM) en empuje agudo. Para este propósito, se desarrollan kits de diagnóstico que distinguen a los respondedores de los no respondedores para la terapia de plamaféresis. (Spanish)
22 January 2022
0 references
Afereesi kasulikkuse prognoosi väljatöötamine hulgiskleroosiga patsientidel ägeda tõukejõu korral. Selleks töötatakse välja diagnostilised komplektid, mis eristavad reageerijaid plamaphereesi ravile mittereageerijatest. (Estonian)
5 August 2022
0 references
Aferezės naudos prognozavimas pacientams, sergantiems ūmine trauka išsėtine skleroze (IS). Šiuo tikslu kuriami diagnostiniai rinkiniai, kurie skiria atsaką į gydymą plamaferezės gydymui nereagavusius asmenis. (Lithuanian)
5 August 2022
0 references
Razvoj predviđanja u korist afereze u bolesnika s multiplom sklerozom (MS) u akutnom potisku. U tu se svrhu razvijaju dijagnostički kompleti koji razlikuju osobe koje reagiraju na liječenje plamaferezom od onih koji nisu odgovorili na liječenje plamaferezom. (Croatian)
5 August 2022
0 references
Ανάπτυξη πρόβλεψης προς όφελος της αφαίρεσης σε ασθενείς με σκλήρυνση κατά πλάκας (MS) σε οξεία ώση. Για το σκοπό αυτό, αναπτύσσονται διαγνωστικά κιτ που διακρίνουν τους ανταποκριτές από τους μη ανταποκριτές για θεραπεία με πλαταφαίρεση. (Greek)
5 August 2022
0 references
Vývoj predpovede v prospech aferézy u pacientov so sklerózou multiplex (MS) v akútnom ťahu. Na tento účel sa vyvíjajú diagnostické súpravy, ktoré odlišujú pacientov reagujúcich na liečbu plamaferézou od pacientov, ktorí neodpovedali na liečbu plamaferézou. (Slovak)
5 August 2022
0 references
Ennusteen kehittäminen afereesin hyödyksi multippeliskleroosipotilailla akuutissa työntövoimassa. Tätä tarkoitusta varten kehitetään diagnostisia sarjoja, jotka erottavat vasteen saaneet plamafereesihoitoihin osallistumattomista potilaista. (Finnish)
5 August 2022
0 references
Opracowanie prognozy na korzyść aferezy u pacjentów ze stwardnieniem rozsianym (MS) w ostrym ciągu. W tym celu opracowano zestawy diagnostyczne, które odróżniają osoby odpowiadające od osób niereagujących na terapię plamaferezą. (Polish)
5 August 2022
0 references
Az akut tolóerőben lévő sclerosis multiplexben (MS) szenvedő betegek apheresis előnyére vonatkozó előrejelzés kidolgozása. Erre a célra olyan diagnosztikai készleteket fejlesztenek ki, amelyek megkülönböztetik a válaszadókat a nem válaszadóktól a plamapheresis terápia esetében. (Hungarian)
5 August 2022
0 references
Vývoj predikce ve prospěch aferézy u pacientů s roztroušenou sklerózou (MS) v akutním tahu. Za tímto účelem jsou vyvinuty diagnostické soupravy, které odlišují respondenty od non-respondérů pro léčbu plamaferézou. (Czech)
5 August 2022
0 references
Prognozes izstrāde aferēzes ieguvumu multiplās sklerozes (MS) pacientiem akūtas vilces gadījumā. Šim nolūkam tiek izstrādāti diagnostikas komplekti, kas nošķir pacientus, kuriem nav atbildes reakcijas, plamaferēzes terapijā. (Latvian)
5 August 2022
0 references
Tuar a fhorbairt ar mhaithe le haoirí i il-othair scléaróise (MS) a bhfuil géarsá orthu. Chun na críche sin, forbraítear trealamh diagnóiseach a dhéanann idirdhealú ar fhreagróirí ó neamh-fhreagróirí do theiripe plamapheresis. (Irish)
5 August 2022
0 references
Razvoj napovedi v korist afereze pri bolnikih z multiplo sklerozo (MS) v akutni potisk. V ta namen so pripravljeni diagnostični kompleti, ki razlikujejo bolnike, ki so se odzvali na zdravljenje s plamaferezo, od tistih, ki se niso odzvali na zdravljenje s plamaferezo. (Slovenian)
5 August 2022
0 references
Разработване на прогноза в полза на аферезата при пациенти с множествена склероза (МС) с остра тяга. За тази цел се разработват диагностични комплекти, които отличават респондентите от тези, които не отговарят на терапията с пламафереза. (Bulgarian)
5 August 2022
0 references
Żvilupp ta’ tbassir għall-benefiċċju ta’ aferesi f’pazjenti bi sklerożi multipla (MS) f’forza propulsiva akuta. Għal dan il-għan, jiġu żviluppati kits dijanjostiċi li jiddistingwu lil dawk li rrispondew minn dawk li ma rrispondewx għat-terapija tal-plamapheresi. (Maltese)
5 August 2022
0 references
Desenvolvimento de uma previsão para o benefício da aférese em doentes com esclerose múltipla (EM) em impulso agudo. Para esta finalidade, os jogos diagnósticos são desenvolvidos que distinguem respondedores dos não-respondedores para a terapia da plamaférese. (Portuguese)
5 August 2022
0 references
Udvikling af en forudsigelse til fordel for aferese hos multipel sklerose (MS) patienter med akut tryk. Til dette formål udvikles diagnostiske kits, der adskiller respondenter fra ikke-respondenter til behandling med plamaferese. (Danish)
5 August 2022
0 references
Dezvoltarea unei predicții în beneficiul aferezei la pacienții cu scleroză multiplă (SM) cu tracțiune acută. În acest scop, sunt elaborate kituri de diagnosticare care să distingă respondenții de cei care nu au răspuns la tratament pentru terapia cu plamafereză. (Romanian)
5 August 2022
0 references
Utveckling av en prediktion till förmån för aferes hos patienter med multipel skleros (MS) i akut dragkraft. För detta ändamål utvecklas diagnostiska kit som skiljer responders från icke-responders för plamaferes terapi. (Swedish)
5 August 2022
0 references
Identifiers
DE_TEMPORARY_7634
0 references